AI assistant
Q/C TECHNOLOGIES, INC. — Director's Dealing 2020
Jan 7, 2020
35313_dirs_2020-01-07_ca075ee1-540e-49b6-9fd2-965c7b463b71.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Akers Biosciences, Inc. (AKER)
CIK: 0001321834
Period of Report: 2019-12-06
Reporting Person: Hudson Bay Capital Management LP (10% Owner)
Reporting Person: Gerber Sander (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, no par value ("Common Stock") | 84665 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrant (right to buy) | $241.92 | 2023-04-13 | Common Stock (1296) | Indirect | |
| Warrant (right to buy) | $241.92 | 2018-04-17 | Common Stock (589) | Indirect |
Footnotes
F1: The securities are held by Hudson Bay Master Fund, Ltd. (the "Fund"). Hudson Bay Capital Management LP (the "Investment Manager") serves as the investment manager of the Fund. As such, the Investment Manager may be deemed to have beneficial ownership of the securities held by the Fund. As the managing member of the general partner of Hudson Bay Capital Management LP, Mr. Sander Gerber may be deemed to have beneficial ownership of the securities held by the Fund. Each Reporting Person disclaims beneficial ownership of the securities held by the Fund, except to the extent of its or his pecuniary interest therein.